← Open Payments lookup

MENGFEN MOSELEY: Open Payments

NPI 1720316979 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,682 in 73 payments from 7 companies in 2025. Trend: 2023 $1,249 · 2024 $1,775 · 2025 $1,682

Food & beverage: $1,673Education: $9
CompanyPaymentsAmount
Alkermes, Inc.28$591
Janssen Pharmaceuticals, Inc9$258
Teva Pharmaceuticals USA, Inc.9$228
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$210
E.R. Squibb & Sons, L.L.C.11$194
Otsuka America Pharmaceutical, Inc.5$117
Neurocrine BioSciences, Inc.3$84

Products named: ARISTADA, INVEGA SUSTENNA, UZEDY, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, INGREZZA.

Industry payments across CA — which companies pay providers there.